Gave Arexvy instead of Abrysvo; Gave Arexvy instead of Abrysvo; This non-serious prospective pregnancy case was reported by a consumer via interactive digital media and described the occurrence of vaccine exposure during pregnancy in a female patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis. Co-suspect products included RSV vaccine prot. subunit PreF 2v (Abrysvo) for prophylaxis. On an unknown date, the patient received Arexvy and Abrysvo. On an unknown date, an unknown time after receiving Arexvy, the patient experienced vaccine exposure during pregnancy (Verbatim: Gave Arexvy instead of Abrysvo) and wrong vaccine administered (Verbatim: Gave Arexvy instead of Abrysvo). The outcome of the vaccine exposure during pregnancy and wrong vaccine administered were unknown. Pregnancy exposure: Pregnancy Exposure (Arexvy): To mother in third trimester Pregnancy Exposure (Abrysvo): To mother in third trimester Pregnancy Outcome: Pregnancy was ongoing Additional Information: GSK Receipt Date: 16-JAN-2024 The reporter reported that a pregnant patient received Arexvy instead of Abrysvo, which led to vaccine exposure during pregnancy and wrong vaccine administered. But in the end baby were totally fine. The patient did not had a lot of time to decide on whether or not to get the maternal vaccine. The patient read there was a higher risk of a preterm labor so wanted to ask if that happened to anyone who got it or any other issues, also, thinking of doing the Beyfortus shot for baby.